Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001600620-24-000110
Filing Date
2024-11-12
Accepted
2024-11-12 18:57:21
Documents
1
Period of Report
2024-11-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1731455835.html 3  
1 FORM 3 wk-form3_1731455835.xml 3 1577
  Complete submission text file 0001600620-24-000110.txt   2984
Mailing Address C/O PURE BIOSCIENCE 1725 GILLESPIE WAY EL CAJON CA 92020
Business Address
Johnson Craig A (Reporting) CIK: 0001370348 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36421 | Film No.: 241450550

Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

EIN.: 981231763 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)